Table 1. Demographic and baseline characteristics of included
samples |
Table 1. Demographic and baseline characteristics of
included samples |
Table 1. Demographic and baseline
characteristics of included samples |
Table 1. Demographic and
baseline characteristics of included samples |
|
Total |
Male |
Female |
|
N=17,884 |
N=7,468 |
N=10,416 |
Demographic characteristics |
Demographic
characteristics |
Demographic characteristics |
Demographic characteristics |
Age, year, mean (SD) |
42.07 (20.68) |
40.72 (22.17) |
43.03
(19.49) |
Male, n (%) |
7,468 (41.76) |
- |
- |
Serum IgE, mean (SD) |
268.04 (544.08) |
327.72 (616.81) |
225.25
(480.76) |
Diseases |
|
|
|
Allergic Rhinitis, n (%) |
5,470 (30.59) |
2,492 (13.93) |
2,978
(16.65) |
Asthma, n (%) |
3,613 (20.2) |
1,633 (9.13) |
1,980
(11.07) |
Dermatitis, n (%) |
5,093 (28.48) |
2,000 (11.18) |
3,093
(17.29) |
Urticaria, n (%) |
4,760 (26.62) |
1,608 (8.99) |
3,152
(17.62) |
Any diseases, n (%) |
13,664 (76.4) |
5,627 (31.46) |
8,037
(44.94) |
Drug user |
|
|
|
Adrenaline, n (%) |
1,207 (6.75) |
609 (3.41) |
598
(3.34) |
Antihistamines, n (%) |
2,111 (11.8) |
938 (5.24) |
1,173
(6.56) |
Beta2 Agonist, n (%) |
1,411 (7.89) |
666 (3.72) |
745
(4.17) |
Corticosteroid, n (%) |
459 (2.57) |
173 (0.97) |
286
(1.6) |
Kombinationspr,n (%) |
407 (2.28) |
171 (0.96) |
236
(1.32) |
Leukotrien Receptor Antagonist, n (%) |
381 (2.13) |
198 (1.11) |
183
(1.02) |
Any drugs, n (%) |
3,161 (17.68) |
1,417 (7.92) |
1,744
(9.75) |
IgE, immunoglobulin E; SD, standard deviation. |
IgE, immunoglobulin E;
SD, standard deviation. |
IgE, immunoglobulin E; SD, standard deviation. |
IgE, immunoglobulin E; SD, standard deviation. |